Generic placeholder image

Current Gene Therapy

Editor-in-Chief

ISSN (Print): 1566-5232
ISSN (Online): 1875-5631

Editorial

Gene Therapy (Part I)

Author(s): Xi-Biao Jia and Zhi-Yao He

Volume 20, Issue 1, 2020

Page: [4 - 4] Pages: 1

DOI: 10.2174/156652322001200604150311

conference banner
[1]
Ma CC, Wang ZL, Xu T, et al. The approved gene therapy drugs worldwide: from 1998 to 2019. Biotechnol Adv 2020; 40: 107502
[2]
Chen S, Liu Z, Li M, et al. Potential prognostic predictors and molecular targets for skin melanoma screened by weighted gene co-expression network analysis. Curr Gene Ther 2020; 20(1): 5-14.
[3]
Mo F, Luo Y, Fan D, et al. Integrated analysis of mRNA-seq and miRNA-seq to identify c-MYC, YAP1 and miR-3960 as major players in the anticancer effects of caffeic acid phenethyl ester in human small cell lung cancer cell line. Curr Gene Ther 2020; 20(1): 15-24.
[4]
Morishita R, Shimamura M, Takeya Y, et al. Combined analysis of clinical data on HGF gene therapy to treat critical limb ischemia in Japan. Curr Gene Ther 2020; 20(1): 25-35.

© 2024 Bentham Science Publishers | Privacy Policy